Sort

Search

01/06/2023 "MiR-7 controls cholesterol biosynthesis through posttranscriptional regulation of DHCR24 expression"
Frutos, MFD, Pardo-Marques, V, Torrecilla-Parra, M, Rada, P, Perez-Garcia, A, Martin-Martin, Y, de la Pena, G, Gomez, A, Toledano-Zaragoza, A, Gomez-Coronado, D, Casarejos, MJ, Solis, JM, Rotllan, N, Pastor, O, Ledesma, MD, Valverde, AM, Busto, R, Ramirez, CM. "MiR-7 controls cholesterol biosynthesis through posttranscriptional regulation of DHCR24 expression". Biochimica et Biophysica Acta-Gene Regulatory Mechanisms. 2023; 1866(2)DOI:10.1016/j.bbagrm.2023.194938. PMID:37086967. IF:2.600(Q3/6D).
01/06/2023 Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study
Bermudez-Lopez, M, Marti-Antonio, M, Castro-Boque, E, Bretones, MD, Farras, C, Gonzalez, J, Pamplona, R, Lecube, A, Mauricio, D, Cambray, S, Valdivielso, JM, Fernandez, E. Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study. ATHEROSCLEROSIS. 2023; 375DOI:10.1016/j.atherosclerosis.2023.05.002. PMID:37276714. IF:4.900(Q1/2D).
01/06/2023 The Bittersweet Beat: Diabetes Complications
Rossell, J, Rojo-Lopez, MI, Julve, J, Mauricio, D. The Bittersweet Beat: Diabetes Complications. Journal of Clinical Medicine. 2023; 12(12)DOI:10.3390/jcm12124018. PMID:37373711. IF:3.000(Q1/2D).
01/06/2023 Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis
Nicoara-Farcau, O, Lozano, JJ, Alonso, C, Sidorova, J, Villanueva, C, Albillos, A, Genesca, J, Llop, E, Calleja, JL, Aracil, C, Banares, R, Morillas, R, Poca, M, Penas, B, Augustin, S, Tantau, M, Thompson, M, Perez-Campuzano, V, Baiges, A, Turon, F, Hernandez-Gea, V, Abraldes, JG, Tapias, EA, Torres, F, Bosch, J, Garcia-Pagan, JC. Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis. HEPATOLOGY. 2023; 77(6)DOI:10.1097/HEP.0000000000000316. PMID:36811400. IF:13.000(Q1/1D).
01/06/2023 Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU
Acosta, MBD, Fernandez-Clotet, A, Mesonero, F, Garcia-Alonso, FJ, Casanova, MJ, Fernandez-de la Varga, M, Canete, F, de Castro, L, Gutierrez, A, Sicilia, B, Cano, V, Merino, O, de Francisco, R, Gonzalez-Partida, I, Suris, G, Torrealba, L, Ferreiro-Iglesias, R, Castro, B, Marquez, L, Sobrino, A, Elorza, A, Calvet, X, Varela, P, Vicente, R, Bujanda, L, Lario, L, Mancenido, N, Garcia-Sepulcre, MF, Iglesias, E, Rodriguez, C, Piqueras, M, Rosique, JAF, Lucendo, AJ, Benitez, O, Garcia, M, Olivares, D, Gonzalez-Munoza, C, Lopez-Cauce, B, Alvarado, VJM, Spicakova, K, Brotons, A, Bermejo, F, Almela, P, Ispizua, N, Gilabert, P, Tardillo, C, Munoz, F, Navarro, P, Dominguez, REM, Sendra, P, Hinojosa, E, Sainz, E, Martin-Arranz, MD, Carpio, D, Ricart, E, Caballol, B, Nunez, L, Barrio, J, Gisbert, JP, Iborra, M, Calafat, M, Hernandez, V, Perez, R, Cabriada, JL, Domenech, E, Rodriguez-Lago, I. Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2023; 118(6)DOI:10.14309/ajg.0000000000002152. PMID:36516073. IF:8.500(Q1/1D).
01/06/2023 Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome
Magaz, M, Giudicelli-Lett, H, Nicoara-Farcau, O, Rajoriya, N, Goel, A, Raymenants, K, Hillaire, S, Crespo, G, TTllez, L, Elkrief, L, Fondevila, C, Orts, L, Nery, F, Shukla, A, Larrue, H, Fundora, Y, Degroote, H, Aguilera, V, LLop, E, Turco, L, Indulti, F, Gioia, S, Tosetti, G, Bitto, N, Becchetti, C, Alvarado, E, Roig, C, Diaz, R, Praktiknjo, M, Konicek, AL, Soy, G, Olivas, P, Fortea, JI, Masnou, H, Puente, A, Ardevol, A, Alvarez-Navascues, C, Romero, M, Scheiner, B, Semmler, G, Mandorfer, M, Damiao, F, Baiges, A, Turon, F, Simon-Talero, M, Gonzalez-Alayon, C, Diaz, A, Garcia-Criado, A, de Gottardi, A, Reverter, E, Blasi, A, Genesca, J, Roux, O, Francoz, C, Ferreira, CN, Reiberger, T, Rodrfguez, M, Morillas, RM, Crespo, J, Trebicka, J, Banares, R, Villanueva, C, Berzigotti, A, Primignani, M, La Mura, V, Riggio, O, Schepis, F, Procopet, B, Verhelst, X, Calleja, JL, Bureau, C, Albillos, A, Nevens, F, Hernandez-Gea, V, Tripathi, D, Rautou, PE, Durand, F, Garcia-Pagan, JC. Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome. TRANSPLANTATION. 2023; 107(6)DOI:10.1097/TP.0000000000004444. PMID:36479977. IF:5.500(Q1/1D).
01/06/2023 Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set
Morillon, MB, Norup, A, Singh, JA, Dalbeth, N, Taylor, WJ, Kennedy, MA, Pedersen, BM, Grainger, R, Tugwell, P, Perez-Ruiz, F, Diaz-Torne, C, Edwards, NL, Shea, B, Ellingsen, TJ, Christensen, R, Stamp, LK. Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023; 60DOI:10.1016/j.semarthrit.2023.152191. PMID:36963128. IF:4.600(Q1/2D).
01/06/2023 Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib
de Velasco G., Alonso-Gordoa T., Rodríguez-Vida A., Anguera G., Campayo M., Pinto Á., Ortega E.M., Gallardo E., Núñez N.F., García-Carbonero I., Reig O., Méndez-Vidal M.J., Fernández-Calvo O., Cassinello N.V., Torregrosa D., López-Martín A., Rosero A., Valiente P.G., de España C.G., Climent M.A., Santasusana M.D., Sánchez Á.R., González I.C., Afonso R., García del Muro X., Casinello J., Fernández-Parra E.M., García Sánchez L., Afonso J., Polo S.H., Asensio Ú.. Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib. Clinical Genitourinary Cancer. 2023; 21(3)DOI:10.1016/j.clgc.2022.11.021. PMID:36610891. IF:2.300(Q2/5D).